Trial Identifier: | D6830C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05110976 |
Start Date: | December 2021 |
Primary Completion Date: | July 2023 |
Study Completion Date: | July 2023 |
Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
DE | Frankfurt, DE, 60596 |
DE | Großhansdorf, DE, 22927 |
DE | Magdeburg, DE, 39120 |
DE | Wiesbaden, DE, 65187 |
GB | London, GB, HA1 3UJ |
GB | NOTTINGHAM, GB, NG5 1PB |
US, AZ | Tempe, AZ, US, 85283 |
US, CA | Glendale, CA, US, 91206 |
US, CA | San Jose, CA, US, 95117 |
US, MA | North Dartmouth, MA, US, 02747 |
US, MD | White Marsh, MD, US, 21162 |
US, MO | Kansas City, MO, US, 64114 |
US, NC | Raleigh, NC, US, 27607 |
US, OR | Portland, OR, US, 97202 |
US, TX | El Paso, TX, US, 79903 |